Home> Products> potential gastrointestinal disturbances

{ "products": [ { "_id": "68832b7f217a4e897b4812dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SMITHCON ACID TABLETS", "description": "SMITHCON ACID TABLETS is a scientifically formulated oral medication designed to offer comprehensive relief from gastrointestinal disturbances such as acidity, gas, bloating, indigestion, and abdominal cramps. This tablet combines three powerful ingredients: Dicyclomine Hydrochloride 10 mg, Simethicone 20 mg, and Ranitidine Hydrochloride 150 mg. Together, these compounds address various symptoms of digestive distress and provide fast, effective, and lasting comfort.\n\nWhat is SMITHCON ACID TABLETS?\nSMITHCON ACID TABLETS is a combination medication containing three active ingredients:\n\nDicyclomine Hydrochloride 10 mg – An antispasmodic agent that works by relaxing the smooth muscles of the stomach and intestines, helping relieve painful cramps, spasms, and abdominal discomfort.\n\nSimethicone 20 mg – An anti-foaming agent that breaks down gas bubbles in the stomach and intestines, providing quick relief from bloating, fullness, and abdominal pressure.\n\nRanitidine Hydrochloride 150 mg – A histamine-2 (H2) receptor blocker that reduces the production of stomach acid, effectively treating heartburn, acid reflux, and indigestion.\n\nUses of SMITHCON ACID TABLETS:\nSMITHCON ACID TABLETS is used to treat a variety of gastrointestinal conditions, including:\n\nAcid indigestion and heartburn\n\nGastroesophageal reflux disease (GERD)\n\nFlatulence and bloating\n\nAbdominal cramps and spasms\n\nIrritable bowel syndrome (IBS)\n\nFunctional dyspepsia\n\nExcessive stomach acid production\n\nThe triple-action mechanism provides targeted relief from gas, acidity, and muscle spasms, making SMITHCON ACID TABLETS an ideal choice for patients experiencing multiple digestive complaints.\n\nSide Effects of SMITHCON ACID TABLETS:\nWhile generally well-tolerated, some patients may experience side effects such as:\n\nDry mouth\n\nDizziness or light-headedness\n\nNausea or constipation\n\nBlurred vision\n\nDrowsiness\n\nAllergic reactions (rare)\n\nHeadache or mild abdominal discomfort\n\nIf any of these symptoms persist or worsen, it is advised to consult a healthcare professional.\n\nPrecautions Before Using SMITHCON ACID TABLETS:\nBefore starting SMITHCON ACID TABLETS, inform your doctor if you have:\n\nGlaucoma\n\nEnlarged prostate\n\nObstructive gastrointestinal conditions\n\nLiver or kidney disease\n\nHeart conditions\n\nPregnancy or breastfeeding\n\nAvoid alcohol and activities requiring mental alertness if you experience drowsiness or dizziness while taking this medication.\n\nDrug Interactions: What Drugs Interact With SMITHCON ACID TABLETS?\nThe following medications may interact with SMITHCON ACID TABLETS:\n\nAnticholinergic drugs (may enhance side effects of dicyclomine)\n\nAntacids or sucralfate (may interfere with ranitidine absorption)\n\nKetoconazole, itraconazole (reduced absorption due to ranitidine)\n\nCNS depressants like alcohol, sedatives (increased risk of drowsiness)\n\nDigoxin or blood thinners (may be affected by changes in stomach acid levels)\n\nAlways inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.\n\nParaphrased Clinical Note:\nRanitidine, dicyclomine hydrochloride, and simethicone tablets are a combination medication used to treat various gastrointestinal issues. Ranitidine is an H2 blocker that reduces stomach acid production, helping with heartburn and indigestion. Dicyclomine is an antispasmodic that relaxes stomach and intestinal muscles, relieving cramps and pain. Simethicone helps to relieve gas and bloating by breaking down gas bubbles.\n\nConclusion:\nSMITHCON ACID TABLETS offers a dependable solution for those suffering from common gastrointestinal complaints such as acidity, gas, and abdominal pain. With its triple-action blend of dicyclomine hydrochloride 10mg, simethicone 20 mg, and ranitidine hydrochloride 150 mg, it provides swift and targeted relief for a better quality of life. Consult your physician before use and follow dosage guidelines to maximize its benefits.", "price": 70.0, "discountamount": 21.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2152, "imageuri": "https://productimages.withfloats.com/actual/68832b83093884639e4d0879.png", "tileimageuri": "https://productimages.withfloats.com/tile/68832b83093884639e4d0879.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-25T07:00:15.779Z", "updatedon": "2025-07-25T07:00:15.779Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/smithcon-acid-tablets/2152", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ranitidine dicyclomine hydrochloride and simethicone tablets", "category": "GASTROLOGYRANGE", "tags": [ "dicyclomine hydrochloride and simethicone tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e7de4a6e2f4114c6f8d28", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LAXAVATAR LB DS ", "description": "LAXAVATAR LB DS \nLactic Acid Bacillus 120 Million\nIntroduction\nLAXAVATAR LB DS is a probiotic supplement containing Lactic Acid Bacillus, designed to promote gastrointestinal health and support the balance of intestinal flora. It helps in maintaining digestive balance and potentially offers benefits in managing various gastrointestinal conditions.\n\nComposition\n\nLactic Acid Bacillus: Each dose of LAXAVATAR LB DS provides 120 million colony-forming units (CFUs) of Lactic Acid Bacillus. This probiotic strain is known for its ability to restore and maintain the natural balance of bacteria in the gut.\nMechanism of Action\nLactic Acid Bacillus works through several mechanisms to support gastrointestinal health:\n\nRestoration of Gut Flora: Helps restore the natural balance of beneficial bacteria in the gut, which may be disrupted due to factors like antibiotic use or dietary changes.\nSupports Digestive Function: Enhances digestion and nutrient absorption by promoting a healthy gut environment.\nImmune Modulation: Modulates the immune response within the gut, supporting overall immune function and health.\nIndications\nLAXAVATAR LB DS is indicated for:\n\nDigestive Health: Supports digestive function and helps maintain gastrointestinal balance.\nAntibiotic-Associated Diarrhea: Helps prevent and manage diarrhea associated with antibiotic use by replenishing beneficial gut bacteria.\nIrritable Bowel Syndrome (IBS): May provide symptomatic relief in individuals with IBS by promoting gut health.\nGeneral Well-being: Contributes to overall well-being by supporting a healthy digestive system.\nDosage and Administration\n\nThe typical dosage for adults and children over 12 years old is one capsule daily, preferably taken with a meal.\nCapsules should be swallowed whole with water and not chewed or crushed.\nIt is recommended to use LAXAVATAR LB DS regularly for best results, especially during periods of antibiotic therapy or digestive disturbances.\nSide Effects\nLAXAVATAR LB DS is generally well-tolerated. Common side effects, if any, may include mild gastrointestinal symptoms such as:\n\nBloating\nFlatulence\nMild abdominal discomfort\nSevere side effects are rare but may include allergic reactions in sensitive individuals. Discontinue use and consult a healthcare professional if adverse reactions occur.\n\nPrecautions\n\nUse with caution in individuals with compromised immune systems or severe underlying health conditions, as probiotics may interact with medications or exacerbate existing conditions.\nConsult a healthcare professional before starting LAXAVATAR LB DS, especially if pregnant, nursing, or undergoing medical treatment.\nConclusion\nLAXAVATAR LB DS provides a convenient and effective way to support digestive health with its formulation of Lactic Acid Bacillus. By replenishing beneficial gut bacteria, it helps maintain gastrointestinal balance, supports digestion, and contributes to overall well-being. Regular use of LAXAVATAR LB DS can be beneficial in managing digestive disturbances, promoting gut health, and enhancing immune function. As with any dietary supplement, it is advisable to seek guidance from a healthcare provider to determine the most appropriate use based on individual health needs.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 85.0, "discountamount": 25.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Gut Flora", "gut health", "Regular use", "one capsule", "best results", "effective way", "typical dosage", "antibiotic use", "immune systems", "appropriate use", "natural balance", "dietary changes", "immune response", "LAXAVATAR LB DS", "probiotic strain", "intestinal flora", "Digestive Health", "digestive balance", "medical treatment", "adverse reactions", "Immune Modulation", "dietary supplement", "allergic reactions", "antibiotic therapy", "General Well-being", "symptomatic relief", "several mechanisms", "overall well-being", "Digestive Function", "healthcare provider", "nutrient absorption", "beneficial bacteria", "existing conditions", "Common side effects", "Severe side effects", "probiotic supplement", "Lactic Acid Bacillus", "sensitive individuals", "digestive disturbances", "healthcare professional", "gastrointestinal health", "overall immune function", "beneficial gut bacteria", "healthy gut environment", "individual health needs", "gastrointestinal balance", "healthy digestive system", "Irritable Bowel Syndrome", "Mild abdominal discomfort", "Antibiotic-Associated Diarrhea", "mild gastrointestinal symptoms", "120 million colony-forming units", "various gastrointestinal conditions", "severe underlying health conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1937, "imageuri": "https://productimages.withfloats.com/actual/668e7de7d81299e9814a2653.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e7de7d81299e9814a2653.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:26:12.188Z", "updatedon": "2024-07-10T12:26:12.188Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/laxavatar-lb-ds-/1937", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LAXAVATAR LB DS ", "category": "GENERAL RANGE", "tags": [ "Lactic Acid Bacillus how to use", "", "Lactic Acid Bacillus Capsules", "Lactic acid Bacillus benefits", "Lactic acid bacillus 60 Million Spores uses", "Lactic acid Bacillus uses for babies", "", "Lactic acid bacillus powder", "Lactic Acid Bacillus Tablet 60 Million Spores", "Lactic acid Bacillus dosage for child" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e745ca846511e502f9489", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Fabrical D3 6L ", "description": "Fabrical D3 6L \nCholecalciferol Vitamin D3 (600,000IU) Injection\nIntroduction\nFabrical D3 6L is a potent vitamin D3 (Cholecalciferol) injection, providing 600,000 IU per dose. This high-dose formulation is designed to address severe vitamin D deficiency and support overall bone health. It is particularly useful for individuals who cannot achieve adequate vitamin D levels through oral supplements or dietary intake.\n\nComposition\n\nCholecalciferol (Vitamin D3) 600,000 IU: A fat-soluble vitamin essential for the absorption of calcium and phosphorus in the body, playing a crucial role in maintaining bone health and calcium homeostasis.\nMechanism of Action\nCholecalciferol (Vitamin D3) undergoes hydroxylation in the liver to form 25-hydroxyvitamin D, which is then converted in the kidneys to its active form, calcitriol (1,25-dihydroxyvitamin D). Calcitriol enhances the intestinal absorption of calcium and phosphorus, supports bone mineralization, and modulates immune function.\n\nIndications\nFabrical D3 6L is indicated for:\n\nSevere Vitamin D Deficiency: To rapidly correct low levels of vitamin D.\nOsteoporosis: To support bone health and prevent fractures.\nHypocalcemia: To assist in the treatment of low calcium levels due to hypoparathyroidism or other conditions.\nRickets and Osteomalacia: To treat and prevent bone disorders caused by vitamin D deficiency.\nMalabsorption Syndromes: In conditions like Crohn’s disease, celiac disease, and bariatric surgery where vitamin D absorption is impaired.\nDosage and Administration\n\nAdult Dosage: Typically, a single dose of 600,000 IU is administered intramuscularly. The frequency of administration depends on the severity of deficiency and the patient's response to treatment.\nAdministration: The injection should be administered by a healthcare professional. It is important to monitor serum calcium and vitamin D levels during treatment to avoid hypercalcemia and vitamin D toxicity.\nSide Effects\nCommon side effects may include:\n\nPain at the injection site\nMild gastrointestinal disturbances (nausea, vomiting)\nFatigue\nHeadache\nMore severe side effects can include:\n\nHypercalcemia (high calcium levels), which may present with symptoms like weakness, confusion, increased thirst and urination, and abdominal pain.\nHypervitaminosis D, resulting from excessive vitamin D intake.\nPrecautions\n\nHypercalcemia: Patients should be monitored for signs of elevated calcium levels.\nKidney Function: Use with caution in patients with renal impairment as vitamin D metabolism and excretion may be affected.\nPregnancy and Lactation: High doses of vitamin D should be used under medical supervision during pregnancy and lactation.\nDrug Interactions\n\nThiazide Diuretics: May increase the risk of hypercalcemia when used with vitamin D.\nAntiepileptic Drugs: Some antiepileptics may decrease vitamin D levels.\nGlucocorticoids: May reduce the effectiveness of vitamin D by impairing calcium absorption.\nConclusion\nFabrical D3 6L, with its high-dose Cholecalciferol (600,000 IU), provides an effective treatment for severe vitamin D deficiency and related conditions. Its ability to rapidly restore adequate vitamin D levels makes it an essential therapeutic option for individuals with significant deficiencies or those who have difficulty absorbing vitamin D. As with any high-dose supplementation, it is critical to use this medication under the guidance of a healthcare professional to ensure safety and efficacy, with regular monitoring to prevent potential side effects such as hypercalcemia and vitamin D toxicity.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "600,000 IU", "High doses", "low levels", "vitamin D.", "single dose", "active form", "Adult Dosage", "crucial role", "serum calcium", "injection site", "abdominal pain", "celiac disease", "bone disorders", "dietary intake", "Fabrical D3 6L", "Kidney Function", "immune function", "other conditions", "renal impairment", "oral supplements", "Drug Interactions", "bariatric surgery", "potent vitamin D3", "related conditions", "regular monitoring", "therapeutic option", "Thiazide Diuretics", "calcium absorption", "Hypervitaminosis D", "low calcium levels", "vitamin D toxicity", "effective treatment", "Antiepileptic Drugs", "medical supervision", "calcium homeostasis", "bone mineralization", "25-hydroxyvitamin D", "fat-soluble vitamin", "overall bone health", "high calcium levels", "Common side effects", "vitamin D absorption", "vitamin D metabolism", "intestinal absorption", "high-dose formulation", "25-dihydroxyvitamin D", "potential side effects", "healthcare professional", "Malabsorption Syndromes", "elevated calcium levels", "significant deficiencies", "More severe side effects", "high-dose Cholecalciferol", "high-dose supplementation", "adequate vitamin D levels", "Cholecalciferol Vitamin D3", "excessive vitamin D intake", "severe vitamin D deficiency", "Mild gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1934, "imageuri": "https://productimages.withfloats.com/actual/668e74610637666af0103bb2.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e74610637666af0103bb2.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T11:45:32.964Z", "updatedon": "2024-07-10T11:45:32.964Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fabrical-d3-6l-/1934", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Fabrical D3 6L ", "category": "GENERAL RANGE", "tags": [ "Vitamin D 600 000 IU injection dosage", "Vitamin D Injection 600 000 price in India", "Vitamin D3 injection dosage for adults", "Vitamin D Injection 600 000 dosage price", "Vitamin D Injection 600 000 brand name", "Vitamin D injection 600 000 benefits" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MYCOPLASM M 500", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mycoplasm-m-500-133669\n\n\n\n\n\n\n", "price": 789.0, "discountamount": 237.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2024-06-29T05:30:13Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mycoplasm-m-500/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f0baed91d281c30c72ddb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 5/ 1000 ", "description": "GLIDAPAFLOZIN M 5/ 1000 \nDapagliflozin (5mg), Metformin (1000mg)\nIntroduction\nGLIDAPAFLOZIN M 5/1000 is a combination medication designed to provide balanced and effective control over Type 2 diabetes. It combines Dapagliflozin (5 mg) and Metformin (1000 mg), offering a synergistic approach to managing blood glucose levels and supporting overall metabolic health.\n\nMechanism of Action\n\nDapagliflozin (5 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (1000 mg): Metformin is a widely used medication for Type 2 diabetes, improving insulin sensitivity, reducing liver glucose production, and decreasing intestinal glucose absorption. It helps lower blood sugar levels and may also support weight management.\nBenefits\nGLIDAPAFLOZIN M 5/1000 offers several advantages for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin, it provides a balanced approach to blood glucose control and metabolic parameters. This combination can lead to improved glycemic control, weight management, and cardiovascular health.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal to minimize gastrointestinal side effects. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 5/1000 should be taken in the morning to maximize its effectiveness throughout the day. It is important to follow the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 5/1000 may include urinary tract infections, genital infections, gastrointestinal disturbances (such as nausea or diarrhea), and potential vitamin B12 deficiency with long-term use. Patients should be aware of these potential side effects and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 5/1000 offers a balanced and effective treatment option for individuals with Type 2 diabetes, combining the benefits of Dapagliflozin and Metformin in a single tablet. Its dual-action mechanism targets multiple aspects of diabetes management, supporting improved glycemic control and metabolic health. Patients should consult their healthcare provider for personalized advice on dosage, monitoring, and management of potential side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-5-1000-133426", "price": 140.0, "discountamount": 42.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "dose", "meal", "Order", "EMAIL", "nausea", "kidneys", "1000 mg", "morning", "diarrhea", "improved", "concerns", "Patients", "increased", "Metformin", "one tablet", "Conclusion", "monitoring", "weight loss", "information", "individuals", "Introduction", "sterisonline", "tolerability", "sterispharma", "effectiveness", "long-term use", "single tablet", "Dapagliflozin", "CALL/WHATSAPP", "Type 2 diabetes", "dosing schedule", "SGLT2 inhibitor", "GLIDAPAFLOZIN M", "glycemic control", "multiple aspects", "balanced approach", "weight management", "effective control", "blood sugar levels", "several advantages", "Dosage adjustments", "genital infections", "diabetes management", "Common side effects", "personalized advice", "healthcare provider", "individual response", "insulin sensitivity", "synergistic approach", "glucose reabsorption", "metabolic parameters", "blood glucose control", "dual-action mechanism", "cardiovascular health", "Administration Dosage", "combination medication", "potential side effects", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "liver glucose production", "urinary glucose excretion", "effective treatment option", "lower blood glucose levels", "gastrointestinal side effects", "intestinal glucose absorption", "gastrointestinal disturbances", "potential vitamin B12 deficiency" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1318, "imageuri": "https://productimages.withfloats.com/actual/665f0bb10c19ea48b943ceaf.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f0bb10c19ea48b943ceaf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:42:22.464Z", "updatedon": "2024-06-04T12:42:22.464Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glidapaflozin-m-5-1000-/1318", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 5/ 1000 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f0a9787f0960e14a296d5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 10/1000 ", "description": "GLIDAPAFLOZIN M 10/1000 \nDapagliflozin (10mg), Metformin (1000mg)\nIntroduction\nGLIDAPAFLOZIN M 10/1000 is a potent combination medication designed to effectively manage Type 2 diabetes. It combines Dapagliflozin (10 mg) and Metformin (1000 mg), providing a dual-action approach to blood glucose control and overall metabolic health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (1000 mg): Metformin is a cornerstone medication for Type 2 diabetes, improving insulin sensitivity, reducing liver glucose production, and decreasing intestinal glucose absorption. It helps lower blood sugar levels and may also support weight management.\nBenefits\nGLIDAPAFLOZIN M 10/1000 offers several advantages for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin at higher doses, it provides comprehensive control over blood glucose levels and metabolic parameters. This combination can lead to improved glycemic control, weight management, and cardiovascular health.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal to minimize gastrointestinal side effects. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 10/1000 should be taken in the morning to maximize its effectiveness throughout the day. It is important to adhere to the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 10/1000 may include urinary tract infections, genital infections, gastrointestinal disturbances (such as nausea or diarrhea), and potential vitamin B12 deficiency with long-term use. Patients should be aware of these potential side effects and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 10/1000 provides a comprehensive and effective treatment option for individuals with Type 2 diabetes, combining the benefits of Dapagliflozin and Metformin in a single tablet. Its dual-action mechanism targets multiple aspects of diabetes management, supporting improved glycemic control and metabolic health. Patients should consult their healthcare provider for personalized advice on dosage, monitoring, and management of potential side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-10-1000-133425", "price": 205.0, "discountamount": 61.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "meal", "lower", "EMAIL", "Order", "nausea", "kidneys", "morning", "1000 mg", "diarrhea", "concerns", "improved", "Patients", "Metformin", "Conclusion", "monitoring", "one tablet", "weight loss", "information", "individuals", "higher doses", "Introduction", "sterisonline", "tolerability", "sterispharma", "effectiveness", "Dapagliflozin", "CALL/WHATSAPP", "long-term use", "single tablet", "SGLT2 inhibitor", "GLIDAPAFLOZIN M", "dosing schedule", "Type 2 diabetes", "multiple aspects", "glycemic control", "weight management", "genital infections", "blood sugar levels", "Dosage adjustments", "several advantages", "Common side effects", "healthcare provider", "insulin sensitivity", "personalized advice", "individual response", "diabetes management", "glucose reabsorption", "dual-action approach", "metabolic parameters", "blood glucose levels", "dual-action mechanism", "cardiovascular health", "comprehensive control", "Administration Dosage", "blood glucose control", "cornerstone medication", "potential side effects", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "liver glucose production", "urinary glucose excretion", "effective treatment option", "gastrointestinal side effects", "potent combination medication", "gastrointestinal disturbances", "intestinal glucose absorption", "potential vitamin B12 deficiency" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1317, "imageuri": "https://productimages.withfloats.com/actual/665f0a99c06ee12d88cb43d9.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f0a99c06ee12d88cb43d9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:37:43.401Z", "updatedon": "2024-06-04T12:37:43.401Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-m-10-1000-/1317", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 10/1000 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f09d8db9fdd21801ec775", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 10/500 ", "description": "GLIDAPAFLOZIN M 10/500 \nDapagliflozin (10mg), Metformin (500mg) SR\nIntroduction\nGLIDAPAFLOZIN M 10/500 combines two potent medications, Dapagliflozin (10 mg) and Metformin (500 mg, sustained-release), into a single tablet. This formulation offers a comprehensive approach to managing Type 2 diabetes by targeting both blood glucose levels and metabolic health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (500 mg, sustained-release): Metformin is a widely used medication that improves insulin sensitivity, reduces glucose production in the liver, and decreases intestinal glucose absorption. The sustained-release formulation ensures a gradual release of Metformin, minimizing gastrointestinal side effects.\nBenefits\nGLIDAPAFLOZIN M 10/500 offers several benefits for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin, it provides dual-action control over blood glucose levels, enhances insulin sensitivity, and supports overall metabolic health. This combination can lead to improved glycemic control and may also assist in weight management.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 10/500 should be taken in the morning to maximize its effectiveness throughout the day. It is important to follow the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 10/500 may include urinary tract infections, genital infections, and gastrointestinal disturbances such as nausea or diarrhea. These side effects are generally mild and transient, but patients should be aware of them and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 10/500 is a convenient and effective option for individuals with Type 2 diabetes, offering dual-action control over blood glucose levels and metabolic health. Its combination of Dapagliflozin and Metformin provides a comprehensive approach to diabetes management, potentially leading to improved outcomes and better quality of life. Patients should consult their healthcare provider for personalized advice on dosage and monitoring.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-10-500-133423", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SR", "day", "meal", "dose", "life", "liver", "Order", "EMAIL", "lower", "better", "500 mg", "nausea", "quality", "kidneys", "morning", "diarrhea", "concerns", "patients", "Metformin", "Mechanism", "increased", "Conclusion", "one tablet", "convenient", "monitoring", "weight loss", "combination", "information", "individuals", "Introduction", "sterisonline", "tolerability", "sterispharma", "Dapagliflozin", "single tablet", "CALL/WHATSAPP", "effectiveness", "GLIDAPAFLOZIN M", "dosing schedule", "gradual release", "SGLT2 inhibitor", "Type 2 diabetes", "several benefits", "effective option", "glycemic control", "weight management", "improved outcomes", "Dosage adjustments", "genital infections", "glucose production", "personalized advice", "diabetes management", "healthcare provider", "individual response", "dual-action control", "insulin sensitivity", "Common side effects", "blood glucose levels", "glucose reabsorption", "Administration Dosage", "two potent medications", "comprehensive approach", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "urinary glucose excretion", "gastrointestinal side effects", "intestinal glucose absorption", "gastrointestinal disturbances", "sustained-release formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1315, "imageuri": "https://productimages.withfloats.com/actual/665f09da137212f68f05951a.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f09da137212f68f05951a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:34:32.323Z", "updatedon": "2024-06-04T12:34:32.323Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glidapaflozin-m-10-500-/1315", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 10/500 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665eff188da3a81d5c69e749", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA 3D 10/100/1000 SR ", "description": "GLIDAPA 3D 10/100/1000 SR \nDapaflozin 10, Sitagliptin 100 mg & Metformin SR 1000 mg\nIntroduction\nGLIDAPA 3D 10/100/1000 SR is a comprehensive oral medication tailored for the treatment of Type 2 diabetes. This potent combination incorporates Dapagliflozin (10 mg), Sitagliptin (100 mg), and a higher dose of Metformin (1000 mg, sustained release), designed to effectively manage high blood sugar levels throughout the day.\n\nMechanism of Action\n\nDapagliflozin (10 mg): As an SGLT2 inhibitor, Dapagliflozin facilitates the removal of excess glucose from the body via the urine, helping to reduce blood glucose levels and also supporting weight loss and cardiovascular health.\nSitagliptin (100 mg): A DPP-4 inhibitor, Sitagliptin increases the levels of incretin hormones, which enhances the pancreatic response to high blood sugar after meals by increasing insulin production and decreasing glucagon secretion.\nMetformin SR (1000 mg): The higher dose of Metformin in this formulation works to decrease hepatic glucose production, improve insulin sensitivity, and reduce glucose absorption in the intestines. The sustained-release form minimizes gastrointestinal side effects and provides more stable blood sugar control.\nBenefits\nGLIDAPA 3D 10/100/1000 SR offers a potent therapeutic strategy by combining three drugs, each targeting a different aspect of diabetes management. This not only maximizes glucose control but also simplifies the treatment regimen, potentially enhancing patient compliance and reducing the risk of long-term complications.\n\nDosage and Administration\n\nDosage: The dosage should be tailored to the individual’s current health status, effectiveness of the treatment, and tolerability. Regular monitoring of blood glucose and adjustment of the dose may be necessary.\nAdministration: It is recommended to take the medication once daily in the morning, with or without food. The tablet should be swallowed whole to ensure proper release of Metformin over time.\nSide Effects\nCommon side effects may include urinary tract infections (due to Dapagliflozin), potential gastrointestinal disturbances such as nausea or diarrhea (common with Metformin), and a sore throat or nasopharyngitis associated with Sitagliptin. These side effects are generally mild and manageable.\n\nConclusion\nGLIDAPA 3D 10/100/1000 SR is a highly effective option for managing Type 2 diabetes, offering a strategic blend of three medications to control blood sugar levels, improve metabolic health, and reduce the risk of diabetes-related complications. This enhanced formulation is suitable for patients requiring a robust approach to diabetes management, emphasizing the importance of ongoing collaboration with healthcare providers to tailor and optimize treatment.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapa-3d-10-100-1000-sr-134216\n\n\n\n\n\n", "price": 595.0, "discountamount": 178.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "time", "food", "body", "risk", "meals", "Order", "EMAIL", "urine", "nausea", "tablet", "Action", "morning", "1000 mg", "removal", "patients", "Benefits", "diarrhea", "Mechanism", "Conclusion", "Dapaflozin", "intestines", "adjustment", "importance", "individual", "weight loss", "Sitagliptin", "higher dose", "three drugs", "information", "sore throat", "tolerability", "Introduction", "sterisonline", "sterispharma", "Metformin SR", "Dapagliflozin", "CALL/WHATSAPP", "effectiveness", "proper release", "excess glucose", "SGLT2 inhibitor", "Type 2 diabetes", "robust approach", "DPP-4 inhibitor", "strategic blend", "nasopharyngitis", "glucose control", "metabolic health", "different aspect", "effective option", "sustained release", "treatment regimen", "incretin hormones", "three medications", "glucagon secretion", "Regular monitoring", "patient compliance", "glucose absorption", "insulin production", "potent combination", "pancreatic response", "diabetes management", "insulin sensitivity", "Common side effects", "enhanced formulation", "healthcare providers", "blood glucose levels", "ongoing collaboration", "cardiovascular health", "Administration Dosage", "current health status", "sustained-release form", "high blood sugar levels", "long-term complications", "urinary tract infections", "GLIDAPA 3D 10/100/1000 SR", "stable blood sugar control", "hepatic glucose production", "potent therapeutic strategy", "gastrointestinal side effects", "comprehensive oral medication", "diabetes-related complications", "potential gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1303, "imageuri": "https://productimages.withfloats.com/actual/665eff1a8e77bb2c7151ebf4.png", "tileimageuri": "https://productimages.withfloats.com/tile/665eff1a8e77bb2c7151ebf4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:48:40.052Z", "updatedon": "2024-06-04T11:48:40.052Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-3d-10-100-1000-sr-/1303", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA 3D 10/100/1000 SR ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665efaa48ecffe165c350b61", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA TENE 10/20 ", "description": "GLIDAPA TENE 10/20 \nDapagliflozin & Teneligliptin\nIntroduction\nGLIDAPA TENE 10/20 is a cutting-edge oral medication engineered for the management of Type 2 diabetes. This combination therapy includes Dapagliflozin (10 mg) and Teneligliptin (20 mg), two powerful drugs that work synergistically to control high blood sugar levels effectively.\n\nHow It Works\n\nDapagliflozin (10 mg): Dapagliflozin belongs to the class of drugs known as SGLT2 inhibitors. It works by preventing the kidneys from reabsorbing glucose back into the blood, promoting the excretion of glucose through urine. This leads to a reduction in blood glucose levels and can also aid in weight loss and blood pressure control.\nTeneligliptin (20 mg): Teneligliptin is a DPP-4 inhibitor that enhances the body's natural ability to lower blood sugar levels by increasing the release of insulin and decreasing the release of glucagon after meals. This helps to smooth out blood sugar spikes that can occur post-meal.\nBenefits\nGLIDAPA TENE 10/20 offers a comprehensive approach to diabetes management by targeting different pathways in glucose metabolism. The combination of Dapagliflozin and Teneligliptin provides a dual mechanism of action, which can be more effective in lowering blood glucose levels compared to monotherapy. This can also lead to improvements in HbA1c levels, a key indicator of long-term glycemic control.\n\nDosage and Administration\n\nDosage: The standard dosage is one tablet per day, but it should be adjusted based on the patient's specific medical condition, tolerance, and the effectiveness of the treatment.\nAdministration: GLIDAPA TENE 10/20 should be taken in the morning with or without food. Consistent daily intake helps maintain stable drug levels in the blood and ensures maximum efficacy.\nSide Effects\nThe most common side effects associated with GLIDAPA TENE 10/20 may include urinary tract infections due to the increased glucose in urine, and gastrointestinal disturbances such as nausea or constipation. Patients may also experience a slight risk of dehydration and should be advised to maintain adequate fluid intake.\n\nConclusion\nGLIDAPA TENE 10/20 is an innovative medication for managing Type 2 diabetes, providing potent dual-action control over high blood sugar levels. It simplifies the treatment regimen by combining two effective medications into a single daily dose, potentially enhancing patient compliance and improving overall diabetes management. As always, patients should consult their healthcare provider for personalized advice and to adjust the treatment plan as needed to achieve optimal health outcomes.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapa-tene-10-20-134223", "price": 255.0, "discountamount": 76.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "food", "meals", "urine", "Order", "class", "EMAIL", "nausea", "insulin", "morning", "release", "kidneys", "Patients", "glucagon", "Benefits", "excretion", "reduction", "tolerance", "Conclusion", "one tablet", "slight risk", "dehydration", "weight loss", "information", "monotherapy", "Introduction", "GLIDAPA TENE", "sterisonline", "HbA1c levels", "improvements", "constipation", "sterispharma", "effectiveness", "Dapagliflozin", "CALL/WHATSAPP", "key indicator", "dual mechanism", "treatment plan", "standard dosage", "Type 2 diabetes", "DPP-4 inhibitor", "natural ability", "maximum efficacy", "SGLT2 inhibitors", "single daily dose", "treatment regimen", "different pathways", "two powerful drugs", "glucose metabolism", "stable drug levels", "blood sugar spikes", "patient compliance", "personalized advice", "common side effects", "healthcare provider", "combination therapy", "blood glucose levels", "Teneligliptin (20 mg", "innovative medication", "Administration Dosage", "adequate fluid intake", "comprehensive approach", "blood pressure control", "optimal health outcomes", "high blood sugar levels", "Consistent daily intake", "urinary tract infections", "two effective medications", "specific medical condition", "long-term glycemic control", "potent dual-action control", "overall diabetes management", "gastrointestinal disturbances", "cutting-edge oral medication engineered" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1296, "imageuri": "https://productimages.withfloats.com/actual/665efaa8d93d0ca61a4976f3.png", "tileimageuri": "https://productimages.withfloats.com/tile/665efaa8d93d0ca61a4976f3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:29:40.684Z", "updatedon": "2024-06-04T11:29:40.684Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-tene-10-20-/1296", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPA TENE 10/20 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }